United Therapeutics Corp (UTHR):企業の製品パイプライン分析

◆英語タイトル:United Therapeutics Corp (UTHR) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME1845PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
United Therapeutics Corp (United Therapeutics) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company’s products consist of prostacyclin analogues including Remodulin (treprostinil) injection and Tyvaso (treprostinil) inhalation solution; and Orenitram (treprostinil). Adcirca (tadalafil) is a phosphodiesterase type 5 (PDE-5) inhibitor and Unituxin (dinutuximab) is used for monoclonal antibody for oncologic applications are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents and cell-based therapies. The company also develops engineered lungs for transplantation in pre-clinical stage. It manufactures its products in its facility in Silver Spring, Maryland. It markets its products across the US and worldwide primarily Europe, South America and Israel. United Therapeutics is headquartered in Silver Spring, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company United Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
United Therapeutics Corp Company Overview
United Therapeutics Corp Company Snapshot
United Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
United Therapeutics Corp – Pipeline Analysis Overview
Business Description
United Therapeutics Corp – Key Facts
United Therapeutics Corp – Major Products and Services
United Therapeutics Corp Pipeline Products by Development Stage
United Therapeutics Corp Ongoing Clinical Trials by Trial Status
United Therapeutics Corp Pipeline Products Overview
3D Bioprinted Lung Transplant
3D Bioprinted Lung Transplant Product Overview
Blood Vessel
Blood Vessel Product Overview
Heart Valve
Heart Valve Product Overview
Hernia Repair Scaffold
Hernia Repair Scaffold Product Overview
Implantable Artificial Lung
Implantable Artificial Lung Product Overview
Implantable System For Remodulin
Implantable System For Remodulin Product Overview
Implantable System For Remodulin Clinical Trial
PatchPump – SMT-201
PatchPump – SMT-201 Product Overview
PatchPump – SMT-301
PatchPump – SMT-301 Product Overview
Rapid Diagnostic Tool – Lung Transplantation
Rapid Diagnostic Tool – Lung Transplantation Product Overview
Remolife
Remolife Product Overview
Tendon – ACL Repair
Tendon – ACL Repair Product Overview
Trevyent
Trevyent Product Overview
Tyvaso
Tyvaso Product Overview
Tyvaso Clinical Trial
U-Lung
U-Lung Product Overview
UniKidney
UniKidney Product Overview
Unilobe
Unilobe Product Overview
United Therapeutics Corp – Key Competitors
United Therapeutics Corp – Key Employees
United Therapeutics Corp – Key Employee Biographies
United Therapeutics Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
United Therapeutics Corp, Recent Developments
Feb 26, 2020: United Therapeutics reports fourth quarter and full year 2019 financial results
Feb 24, 2020: United Therapeutics announces INCREASE study of Tyvaso meets primary and all secondary endpoints
Feb 04, 2020: United Therapeutics defeats preliminary injunction motion in litigation with Sandoz and RareGen
Dec 13, 2019: United Therapeutics stalled in launching drug delivery system
Oct 30, 2019: United Therapeutics reports third quarter 2019 financial results
Jul 31, 2019: United Therapeutics reports second quarter 2019 financial results
Jun 05, 2019: Liquidia announces clinical update on INSPIRE; targeting NDA filing for LIQ861 in late 2019
May 07, 2019: United Therapeutics and DEKA announce FDA clearance Of The Unity Subcutaneous Delivery System for Remodulin
May 01, 2019: United Therapeutics reports first quarter 2019 financial results
Feb 27, 2019: United Therapeutics announces 2018 fourth quarter and annual financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
United Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
United Therapeutics Corp Pipeline Products by Equipment Type
United Therapeutics Corp Pipeline Products by Indication
United Therapeutics Corp Ongoing Clinical Trials by Trial Status
United Therapeutics Corp, Key Facts
United Therapeutics Corp, Major Products and Services
United Therapeutics Corp Number of Pipeline Products by Development Stage
United Therapeutics Corp Pipeline Products Summary by Development Stage
United Therapeutics Corp Ongoing Clinical Trials by Trial Status
United Therapeutics Corp Ongoing Clinical Trials Summary
3D Bioprinted Lung Transplant - Product Status
3D Bioprinted Lung Transplant - Product Description
Blood Vessel - Product Status
Blood Vessel - Product Description
Heart Valve - Product Status
Heart Valve - Product Description
Hernia Repair Scaffold - Product Status
Hernia Repair Scaffold - Product Description
Implantable Artificial Lung - Product Status
Implantable Artificial Lung - Product Description
Implantable System For Remodulin - Product Status
Implantable System For Remodulin - Product Description
Implantable System For Remodulin - Delivery for Pulmonary Arterial Hypertension (PAH) Clinical Study
Implantable System For Remodulin - Implantable System for Remodulin Post-approval Study
PatchPump - SMT-201 - Product Status
PatchPump - SMT-201 - Product Description
PatchPump - SMT-301 - Product Status
PatchPump - SMT-301 - Product Description
Rapid Diagnostic Tool - Lung Transplantation - Product Status
Rapid Diagnostic Tool - Lung Transplantation - Product Description
Remolife - Product Status
Remolife - Product Description
Tendon - ACL Repair - Product Status
Tendon - ACL Repair - Product Description
Trevyent - Product Status
Trevyent - Product Description
Tyvaso - Product Status
Tyvaso - Product Description
Tyvaso - An Open-label Extension Study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease
Tyvaso - An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects with Pulmonary Arterial Hypertension Currently Using Tyvaso
U-Lung - Product Status
U-Lung - Product Description
UniKidney - Product Status
UniKidney - Product Description
Unilobe - Product Status
Unilobe - Product Description
United Therapeutics Corp, Key Employees
United Therapeutics Corp, Key Employee Biographies
United Therapeutics Corp, Other Locations
United Therapeutics Corp, Subsidiaries
Glossary

★海外企業調査レポート[United Therapeutics Corp (UTHR):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Phoenix Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Navistar International Corporation:企業のM&A・事業提携・投資動向
    Navistar International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navistar International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Bangkok Bank Public Co Ltd:企業の戦略・SWOT・財務情報
    Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Upstream Medical Technologies Ltd:企業の製品パイプライン分析2018
    Summary Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for diagnoses of unstable angina, CVD, ACS, and others. It provides pipe line product such …
  • Exxon Mobil Corp (XOM):石油・ガス:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Mobile Telesystems:企業の戦略・SWOT・財務分析
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Guy’s and St Thomas’ NHS Foundation Trust:企業の戦略的SWOT分析
    Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Ya-Man Ltd:企業の戦略・SWOT・財務分析
    Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report Summary Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Advanced Micro Devices, Inc.:企業の戦略・SWOT・財務情報
    Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Trident Limited:戦略・SWOT・企業財務分析
    Trident Limited - Strategy, SWOT and Corporate Finance Report Summary Trident Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SDL plc (SDL):企業の財務・戦略的SWOT分析
    Summary SDL Plc (SDL) is a technology solution provider that offers language translation technology, services, and content management services. The company’s products include live content architect, live content create, media manager, idiom world server, campaign analytics, email manager, language w …
  • Dominion Energy Inc.:企業の戦略・SWOT・財務分析
    Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sojitz Corp (2768):電力:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …
  • Tokyo Tatemono Co., Ltd.:企業の戦略・SWOT・財務情報
    Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆